$TSRX Trius Therapeutics Inc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Trius Therapeutics Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Trius Therapeutics Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Trius Therapeutics Inc for free.
IRS Number: 201320630
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TSRX
Company Address: 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO 92121
Phone number: (858) 452-0370
Former name: RX3 Pharmaceuticals, Inc.
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Trius Therapeutics Inc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 6.13 | 80,000 | 490,400 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 4.80 | 95,000 | 456,000 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 3.50 | 50,000 | 175,000 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 1.29 | 8,138 | 10,498 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 1.29 | 48,837 | 63,000 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Option Exercise | D | 0.52 | 35,813 | 18,623 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Sell | D | 0.00 | 166,860 | 0 | 0 | 166.9 K to 0 (-100.00 %) |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | Finn John | Chief Scientific Of ... | Sell | D | 0.00 | 3,230 | 0 | 0 | 3.2 K to 0 (-100.00 %) |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Option Exercise | D | 7.77 | 15,000 | 116,550 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Option Exercise | D | 5.05 | 12,000 | 60,600 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Option Exercise | D | 8.26 | 12,000 | 99,120 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Option Exercise | D | 3.50 | 6,000 | 21,000 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Option Exercise | D | 7.57 | 17,441 | 132,028 | 0 | |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Sell | D | 0.00 | 12,114 | 0 | 0 | 12.1 K to 0 (-100.00 %) |
| Sep 13 2013 | TSRX | Trius Therapeutics ... | EASTHAM KARIN | Director | Sell | D | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |